Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2

Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Shion A. Lim, Josef A. Gramespacher, Katarina Pance, Nicholas J. Rettko, Paige Solomon, Jing Jin, Irene Lui, Susanna K. Elledge, Jia Liu, Colton J. Bracken, Graham Simmons, Xin X. Zhou, Kevin K. Leung, James A. Wells
פורמט: Artigo
שפה:Inglês
יצא לאור: Taylor & Francis Group 2021-01-01
סדרה:mAbs
נושאים:
Bispecific
neutralizing antibody
knob-in-hole
COVID-19
SARS-CoV-2
גישה מקוונת:https://www.tandfonline.com/doi/10.1080/19420862.2021.1893426
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים